Eric Garland Sheu, D.Phil., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bariatric Surgery | 17 | 2024 | 1001 | 4.990 |
Why?
|
Gastrectomy | 16 | 2024 | 693 | 4.440 |
Why?
|
Obesity, Morbid | 19 | 2024 | 1298 | 4.240 |
Why?
|
Gastric Bypass | 12 | 2024 | 824 | 3.030 |
Why?
|
Laparoscopy | 7 | 2024 | 2041 | 1.500 |
Why?
|
Weight Loss | 11 | 2024 | 2721 | 1.430 |
Why?
|
Intestine, Small | 3 | 2024 | 1217 | 1.360 |
Why?
|
Gastroesophageal Reflux | 3 | 2023 | 836 | 1.080 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 398 | 0.780 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2024 | 12252 | 0.630 |
Why?
|
Reperfusion Injury | 3 | 2016 | 1039 | 0.580 |
Why?
|
Fundoplication | 2 | 2015 | 145 | 0.550 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2016 | 28 | 0.530 |
Why?
|
Organ Specificity | 1 | 2021 | 1968 | 0.520 |
Why?
|
Immunoglobulin Isotypes | 1 | 2016 | 158 | 0.510 |
Why?
|
Ileum | 2 | 2021 | 558 | 0.500 |
Why?
|
Lipoma | 1 | 2017 | 296 | 0.500 |
Why?
|
Foreign-Body Migration | 1 | 2017 | 220 | 0.480 |
Why?
|
Intestinal Perforation | 1 | 2017 | 254 | 0.480 |
Why?
|
Liposarcoma | 1 | 2017 | 289 | 0.480 |
Why?
|
Obesity | 5 | 2024 | 13090 | 0.440 |
Why?
|
Leukocytes | 1 | 2022 | 2035 | 0.440 |
Why?
|
Hernia, Hiatal | 1 | 2014 | 91 | 0.430 |
Why?
|
Glucose | 2 | 2024 | 4352 | 0.400 |
Why?
|
Diuretics | 1 | 2015 | 614 | 0.390 |
Why?
|
Patient Satisfaction | 1 | 2024 | 3488 | 0.380 |
Why?
|
Endometrial Neoplasms | 1 | 2021 | 1382 | 0.370 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1892 | 0.360 |
Why?
|
Vasodilator Agents | 1 | 2015 | 990 | 0.360 |
Why?
|
Patient Discharge | 1 | 2024 | 3479 | 0.360 |
Why?
|
Body Composition | 1 | 2020 | 2462 | 0.350 |
Why?
|
Lymphocytes | 2 | 2016 | 2614 | 0.340 |
Why?
|
Body Weight | 1 | 2021 | 4627 | 0.340 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3231 | 0.340 |
Why?
|
Blood Glucose | 6 | 2022 | 6430 | 0.330 |
Why?
|
Neutrophils | 2 | 2022 | 3786 | 0.330 |
Why?
|
Autoimmunity | 1 | 2017 | 1361 | 0.320 |
Why?
|
Retrospective Studies | 16 | 2024 | 81762 | 0.310 |
Why?
|
Lymphocyte Transfusion | 1 | 2009 | 232 | 0.300 |
Why?
|
Receptor, erbB-2 | 1 | 2019 | 2603 | 0.300 |
Why?
|
Mice, Inbred C57BL | 5 | 2024 | 22379 | 0.290 |
Why?
|
Adipose Tissue | 1 | 2020 | 3329 | 0.290 |
Why?
|
Learning Curve | 2 | 2021 | 232 | 0.280 |
Why?
|
Postoperative Complications | 4 | 2024 | 15832 | 0.270 |
Why?
|
Telemedicine | 1 | 2024 | 3109 | 0.270 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3109 | 0.260 |
Why?
|
Cytokines | 3 | 2019 | 7453 | 0.260 |
Why?
|
Malaria Vaccines | 6 | 2006 | 165 | 0.250 |
Why?
|
Anastomotic Leak | 2 | 2024 | 170 | 0.250 |
Why?
|
Lithocholic Acid | 1 | 2024 | 23 | 0.240 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1605 | 0.230 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2442 | 0.230 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2024 | 86 | 0.220 |
Why?
|
Gastroplasty | 2 | 2024 | 159 | 0.220 |
Why?
|
North America | 2 | 2024 | 1289 | 0.210 |
Why?
|
Metabolome | 2 | 2021 | 1009 | 0.210 |
Why?
|
Treatment Outcome | 10 | 2024 | 65371 | 0.200 |
Why?
|
Male | 23 | 2024 | 364719 | 0.200 |
Why?
|
Humans | 40 | 2024 | 768166 | 0.200 |
Why?
|
Taurodeoxycholic Acid | 1 | 2021 | 13 | 0.190 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 394 | 0.190 |
Why?
|
Vital Capacity | 1 | 2024 | 996 | 0.190 |
Why?
|
Cholic Acid | 1 | 2020 | 30 | 0.180 |
Why?
|
Middle Aged | 15 | 2024 | 223492 | 0.180 |
Why?
|
Appointments and Schedules | 1 | 2024 | 443 | 0.170 |
Why?
|
Glucose Tolerance Test | 2 | 2020 | 1183 | 0.170 |
Why?
|
Calorimetry, Indirect | 1 | 2020 | 176 | 0.170 |
Why?
|
Valine | 1 | 2021 | 410 | 0.170 |
Why?
|
Stomach | 1 | 2024 | 701 | 0.160 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1695 | 0.160 |
Why?
|
Forced Expiratory Volume | 1 | 2024 | 1831 | 0.160 |
Why?
|
Mice | 14 | 2024 | 82029 | 0.150 |
Why?
|
Leukocyte Count | 1 | 2022 | 1609 | 0.150 |
Why?
|
Jejunum | 1 | 2019 | 475 | 0.140 |
Why?
|
Reoperation | 3 | 2024 | 4329 | 0.140 |
Why?
|
Immunity, Cellular | 3 | 2021 | 1561 | 0.140 |
Why?
|
Postoperative Period | 1 | 2022 | 1826 | 0.140 |
Why?
|
Anti-Obesity Agents | 1 | 2020 | 240 | 0.140 |
Why?
|
Female | 17 | 2024 | 397192 | 0.130 |
Why?
|
Weight Gain | 3 | 2024 | 2359 | 0.130 |
Why?
|
B-Lymphocytes | 2 | 2009 | 4793 | 0.130 |
Why?
|
Animals | 17 | 2024 | 169246 | 0.130 |
Why?
|
Propensity Score | 1 | 2024 | 1969 | 0.130 |
Why?
|
Competitive Behavior | 1 | 2016 | 78 | 0.130 |
Why?
|
Deglutition | 1 | 2017 | 208 | 0.120 |
Why?
|
Adult | 13 | 2024 | 223646 | 0.120 |
Why?
|
General Surgery | 2 | 2017 | 1720 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4978 | 0.110 |
Why?
|
Plasmodium berghei | 2 | 2005 | 161 | 0.110 |
Why?
|
Models, Animal | 1 | 2020 | 2120 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1542 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1247 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2021 | 1135 | 0.100 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2015 | 418 | 0.100 |
Why?
|
Malaria, Falciparum | 3 | 2006 | 1077 | 0.100 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1837 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21206 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 13053 | 0.090 |
Why?
|
Immunization, Secondary | 3 | 2004 | 373 | 0.090 |
Why?
|
Clinical Competence | 2 | 2017 | 4858 | 0.090 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 594 | 0.090 |
Why?
|
Prospective Studies | 4 | 2024 | 54926 | 0.090 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2011 | 124 | 0.090 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8128 | 0.090 |
Why?
|
Protozoan Proteins | 3 | 2006 | 843 | 0.090 |
Why?
|
Lung | 2 | 2024 | 10099 | 0.090 |
Why?
|
Mice, Obese | 2 | 2021 | 417 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2015 | 714 | 0.080 |
Why?
|
Morbidity | 1 | 2015 | 1755 | 0.080 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 244 | 0.080 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2009 | 89 | 0.080 |
Why?
|
Adoptive Transfer | 2 | 2009 | 825 | 0.080 |
Why?
|
Insulin Resistance | 2 | 2020 | 3986 | 0.080 |
Why?
|
Parathyroidectomy | 1 | 2011 | 244 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39348 | 0.080 |
Why?
|
Homeostasis | 1 | 2020 | 3348 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2015 | 2125 | 0.070 |
Why?
|
Liver | 4 | 2021 | 7577 | 0.070 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2021 | 374 | 0.070 |
Why?
|
Vaccines, DNA | 4 | 2004 | 279 | 0.070 |
Why?
|
Fowlpox virus | 2 | 2004 | 21 | 0.070 |
Why?
|
Pilot Projects | 2 | 2020 | 8741 | 0.070 |
Why?
|
Perioperative Care | 1 | 2015 | 1043 | 0.070 |
Why?
|
Hindlimb | 1 | 2009 | 516 | 0.070 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2011 | 594 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2005 | 4648 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2005 | 1441 | 0.070 |
Why?
|
Malaria | 4 | 2005 | 1249 | 0.070 |
Why?
|
Receptors, Immunologic | 3 | 1997 | 1418 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14783 | 0.060 |
Why?
|
Rats | 2 | 2019 | 23760 | 0.060 |
Why?
|
Poxviridae | 1 | 2005 | 37 | 0.060 |
Why?
|
Asthma | 1 | 2024 | 6291 | 0.060 |
Why?
|
Plasmodium falciparum | 2 | 2006 | 1741 | 0.060 |
Why?
|
Parathyroid Hormone | 1 | 2011 | 1804 | 0.060 |
Why?
|
Immunoglobulin M | 1 | 2009 | 1528 | 0.060 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2005 | 318 | 0.060 |
Why?
|
Cohort Studies | 3 | 2023 | 41754 | 0.060 |
Why?
|
Mice, SCID | 1 | 2009 | 2627 | 0.060 |
Why?
|
Pandemics | 1 | 2024 | 8748 | 0.060 |
Why?
|
Societies, Medical | 1 | 2016 | 3968 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9538 | 0.050 |
Why?
|
Interferon-gamma | 4 | 2006 | 3160 | 0.050 |
Why?
|
Lost to Follow-Up | 1 | 2024 | 124 | 0.050 |
Why?
|
Adjuvants, Immunologic | 3 | 2004 | 998 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16726 | 0.050 |
Why?
|
Immunization Schedule | 1 | 2004 | 228 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2021 | 22291 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13014 | 0.050 |
Why?
|
Aged | 5 | 2019 | 171504 | 0.050 |
Why?
|
Ischemia | 1 | 2010 | 1900 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2009 | 2393 | 0.050 |
Why?
|
Duodenum | 1 | 2024 | 495 | 0.050 |
Why?
|
Intestines | 1 | 2010 | 1909 | 0.050 |
Why?
|
Biology | 1 | 2023 | 292 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2021 | 411 | 0.050 |
Why?
|
Anastomosis, Surgical | 1 | 2024 | 991 | 0.040 |
Why?
|
Germ-Free Life | 1 | 2021 | 187 | 0.040 |
Why?
|
Killer Cells, Natural | 3 | 2005 | 2211 | 0.040 |
Why?
|
Adenoma | 1 | 2011 | 2159 | 0.040 |
Why?
|
Sulfotransferases | 1 | 2021 | 150 | 0.040 |
Why?
|
HLA-C Antigens | 2 | 1997 | 146 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2021 | 378 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2020 | 366 | 0.040 |
Why?
|
Bile | 1 | 2020 | 299 | 0.040 |
Why?
|
Sulfates | 1 | 2020 | 379 | 0.040 |
Why?
|
Peptide Fragments | 4 | 2006 | 5151 | 0.040 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2004 | 822 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 361 | 0.040 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1997 | 40 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2010 | 3080 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74944 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4568 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18349 | 0.030 |
Why?
|
Vaccines | 1 | 2005 | 842 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1812 | 0.030 |
Why?
|
Liposomes | 1 | 1997 | 790 | 0.030 |
Why?
|
Inservice Training | 1 | 2016 | 375 | 0.030 |
Why?
|
Amino Acid Sequence | 5 | 2006 | 13421 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20760 | 0.030 |
Why?
|
Peptides | 1 | 2004 | 4354 | 0.020 |
Why?
|
Colon | 1 | 2020 | 1801 | 0.020 |
Why?
|
Genetic Vectors | 4 | 2004 | 3402 | 0.020 |
Why?
|
Blood Proteins | 1 | 1997 | 1191 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9615 | 0.020 |
Why?
|
Kenya | 2 | 2006 | 757 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3428 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4283 | 0.020 |
Why?
|
United States | 1 | 2019 | 73039 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2011 | 184 | 0.020 |
Why?
|
Vaccinia virus | 2 | 2003 | 328 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1996 | 1361 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2006 | 17622 | 0.020 |
Why?
|
Signal Transduction | 2 | 2023 | 23645 | 0.020 |
Why?
|
Spleen | 2 | 2005 | 2295 | 0.020 |
Why?
|
Hypercalcemia | 1 | 2011 | 424 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 2004 | 10266 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 3814 | 0.020 |
Why?
|
Primates | 2 | 2000 | 520 | 0.020 |
Why?
|
Epitopes | 2 | 2006 | 2528 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1996 | 5505 | 0.020 |
Why?
|
Vaccines, Subunit | 1 | 2006 | 159 | 0.020 |
Why?
|
Poxviridae Infections | 1 | 2005 | 10 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14488 | 0.020 |
Why?
|
HLA-DR2 Antigen | 1 | 2004 | 45 | 0.010 |
Why?
|
Myelin Proteolipid Protein | 1 | 2004 | 107 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1997 | 4937 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2006 | 609 | 0.010 |
Why?
|
Vaccines, Combined | 1 | 2004 | 70 | 0.010 |
Why?
|
Sporozoites | 1 | 2004 | 83 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8890 | 0.010 |
Why?
|
Vaccines, Attenuated | 1 | 2004 | 314 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11928 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2006 | 1156 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 1765 | 0.010 |
Why?
|
Antigens, Protozoan | 1 | 2003 | 315 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1183 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2003 | 1353 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3044 | 0.010 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2000 | 330 | 0.010 |
Why?
|
Calorimetry, Differential Scanning | 1 | 1997 | 97 | 0.010 |
Why?
|
Calcium | 1 | 2011 | 5792 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 6004 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6329 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 1997 | 416 | 0.010 |
Why?
|
Receptors, KIR | 1 | 1997 | 114 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2005 | 1815 | 0.010 |
Why?
|
Superantigens | 1 | 1996 | 124 | 0.010 |
Why?
|
Immunoassay | 1 | 2000 | 746 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2003 | 1854 | 0.010 |
Why?
|
Thermodynamics | 1 | 1997 | 591 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14729 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1997 | 1142 | 0.010 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 1997 | 352 | 0.010 |
Why?
|
Longevity | 1 | 2003 | 1077 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6231 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1997 | 1683 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4352 | 0.010 |
Why?
|
Clone Cells | 1 | 1996 | 1670 | 0.010 |
Why?
|
Cell Line | 2 | 1997 | 15597 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2011 | 59629 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9343 | 0.010 |
Why?
|
Vaccination | 1 | 2004 | 3437 | 0.010 |
Why?
|
HLA Antigens | 1 | 1996 | 1334 | 0.010 |
Why?
|
Ligands | 1 | 1997 | 3284 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2004 | 3250 | 0.010 |
Why?
|
Transfection | 1 | 1996 | 5755 | 0.000 |
Why?
|
Binding Sites | 1 | 1997 | 6020 | 0.000 |
Why?
|
Infant | 1 | 2003 | 36535 | 0.000 |
Why?
|
Child, Preschool | 1 | 2003 | 42669 | 0.000 |
Why?
|
Child | 1 | 2003 | 80917 | 0.000 |
Why?
|
Adolescent | 1 | 2003 | 89169 | 0.000 |
Why?
|